RepliCel Life Sciences Inc (REPCF)
OTHER OTC:REPCF
Holding REPCF?
Track your performance easily

RepliCel Life Sciences (REPCF) Financial Statements

22 Followers

RepliCel Life Sciences Financial Overview

RepliCel Life Sciences's market cap is currently ―. The company's EPS TTM is $0.009; its P/E ratio is 4.67; RepliCel Life Sciences is scheduled to report earnings on May 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total RevenueC$ 88.43KC$ 88.43KC$ 88.43KC$ 88.43KC$ 88.43K
Gross ProfitC$ 88.43KC$ 88.43KC$ 88.43KC$ 88.43KC$ 88.43K
EBITC$ -63.64KC$ -127.53KC$ 2.22MC$ -385.78KC$ -558.51K
EBITDAC$ -45.68KC$ -118.55KC$ 2.23MC$ -385.78KC$ -539.62K
Net Income Common StockholdersC$ -187.94KC$ -251.83KC$ 2.03MC$ -818.60KC$ -558.51K
Balance Sheet-
Cash Cash Equivalents And Short Term InvestmentsC$ 148.95KC$ 16.64KC$ 76.41KC$ 32.48KC$ 232.77K
Total AssetsC$ 302.57KC$ 202.53KC$ 287.79KC$ 331.46KC$ 495.65K
Total DebtC$ 60.82KC$ 60.82KC$ 60.00KC$ 40.96KC$ 40.96K
Net DebtC$ -88.13KC$ 44.18KC$ -16.41KC$ 8.48KC$ -191.81K
Total LiabilitiesC$ 5.15MC$ 4.99MC$ 4.82MC$ 6.97MC$ 6.55M
Stockholders EquityC$ -4.98MC$ -4.78MC$ -4.53MC$ -6.64MC$ -6.05M
Cash Flow-
Free Cash FlowC$ -284.16KC$ -160.13KC$ 337.49K-C$ -1.55M
Operating Cash FlowC$ -284.16KC$ -160.13KC$ 337.49K-C$ -1.55M
Investing Cash FlowC$ 17.25KC$ 17.25K---
Financing Cash FlowC$ 315.13KC$ 100.36KC$ -293.56K-C$ 1.35M
Currency in CAD

RepliCel Life Sciences Earnings and Revenue History

RepliCel Life Sciences Debt to Assets

RepliCel Life Sciences Cash Flow

RepliCel Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis